Volume 23, Number 7—July 2017
CME ACTIVITY - Research
Risk Factors for Legionella longbeachae Legionnaires’ Disease, New Zealand
In support of improving patient care, this activity has been planned and implemented by Medscape, LLC and Emerging Infectious Diseases. Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Medscape, LLC designates this Journal-based CME activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All other clinicians completing this activity will be issued a certificate of participation. To participate in this journal CME activity: (1) review the learning objectives and author disclosures; (2) study the education content; (3) take the post-test with a 75% minimum passing score and complete the evaluation at http://www.medscape.org/journal/eid; and (4) view/print certificate.
Release date: June 16, 2017; Expiration date: June 16, 2018
Upon completion of this activity, participants will be able to:
• Assess the epidemiology and prognosis of Legionnaires’ disease.
• Distinguish the most common chronic illness associated with Legionella longbeachae pneumonia.
• Assess risk factors for L. longbeachae pneumonia.
• Evaluate potential preventive measures for L. longbeachae pneumonia.
Kristina B. Clark, PhD, Copyeditor, Emerging Infectious Diseases. Disclosure: Kristina B. Clark, PhD, has disclosed the following relevant financial relationships: owns stock, stock options, or bonds from Cooper Companies, Inc.; McKesson Corp; Medtronic; STERIS; Bio-Techne Corp.
Charles P. Vega, MD, Health Sciences Clinical Professor, UC Irvine Department of Family Medicine; Associate Dean for Diversity and Inclusion, UC Irvine School of Medicine, Irvine, California, USA. Disclosure: Charles P. Vega, MD, has disclosed the following financial relationships: served as an advisor or consultant for McNeil Consumer Healthcare; served as a speaker or a member of a speakers bureau for Shire Pharmaceuticals.
Disclosures: Emma Kenagy, MPH; Patricia C. Priest, MBChB, MPH, DPhil; Claire M. Cameron, PhD; Debbie Smith, BCApSc, GUPEHSc, DPH; Pippa Scott, PhD, MSc, BVSc; Vicki Cho, MBChB; Peter Mitchell, MBBS, DPH; and David R. Murdoch, MD, have disclosed no relevant financial relationships.>
- Page created: June 15, 2017
- Page last updated: June 15, 2017
- Page last reviewed: June 15, 2017
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)